Summary

The global contraceptive industry plays a pivotal role in shaping reproductive health, population control, and gender equality efforts across the world. With a growing awareness of family planning, increasing government initiatives, and a wider acceptance of sexual wellness, the contraceptive market has evolved into a dynamic and socially significant segment of the healthcare sector. Contraceptives, including both modern and traditional methods, are not only vital in preventing unintended pregnancies but also in empowering individuals—particularly women—to make informed choices about their reproductive health and future. The industry encompasses a broad range of products such as oral pills, condoms, intrauterine devices (IUDs), implants, injectables, patches, vaginal rings, and sterilization procedures. It also includes digital solutions and fertility tracking apps, reflecting the increasing influence of technology in personal health management. One of the major driving forces behind the contraceptive market's growth is the rising global focus on women's health and the empowerment of women through reproductive autonomy. In both developing and developed countries, access to contraceptives has become a key indicator of healthcare equity and gender-sensitive policymaking. According to various international agencies, improved contraceptive use leads to reductions in maternal mortality, teenage pregnancies, and unsafe abortions.

According to the research report “Global Contraceptive Market Outlook, 2030” published by Bonafide Research, the global market is projected to reach market size of USD 45.46 Billion by 2030 increasing from USD 31.20 Billion in 2024, growing with 6.61% CAGR by 2025-30. Government-funded awareness campaigns, NGO initiatives, and public-private partnerships have all contributed to enhancing the availability and affordability of contraceptive products, particularly in underserved regions. Moreover, educational outreach and cultural shifts are helping to reduce the stigma associated with contraception, especially in conservative societies, further expanding the market's potential. The industry is also driven by a diverse consumer base with changing preferences, demanding innovation in both product design and delivery methods. While male condoms and oral contraceptive pills remain the most widely used methods globally, there has been significant growth in long-acting reversible contraceptives (LARCs) like IUDs and implants, which offer extended protection with minimal maintenance. These options are gaining popularity among women looking for hassle-free, reliable solutions. Additionally, the rise in e-commerce platforms and discreet distribution channels has increased accessibility, especially among younger consumers who prefer privacy and convenience. The development of male contraceptive options, though still in its early stages, is an area of intense research and may become a game-changer in the next decade, offering more balanced responsibility in family planning.

Market Drivers

• Rising Government and NGO Support for Family Planning Programs: Governments and global organizations like WHO, UNFPA, and USAID are actively funding contraceptive distribution and education campaigns, especially in low- and middle-income countries. These initiatives aim to improve access, reduce unintended pregnancies, and promote maternal health. Subsidies, free distribution in public health centers, and community outreach programs are significantly expanding the user base.
• Increasing Awareness and Demand for Reproductive Autonomy: The global rise in women's education, urbanization, and workforce participation has led to a growing emphasis on reproductive rights and personal health. Women and couples are increasingly prioritizing planned pregnancies, driving demand for a wide range of contraceptive options—especially those that are reversible and discreet.

Market Challenges

• Cultural and Religious Opposition in Certain Regions: In many parts of the world, especially in conservative societies, religious beliefs, social stigma, and misinformation discourage contraceptive use. This resistance affects education campaigns, access to services, and adoption rates—creating a significant barrier to market penetration.
• Side Effects and Health Concerns Associated with Hormonal Contraceptives: Despite their effectiveness, hormonal methods such as pills, patches, and implants often raise concerns related to weight gain, mood swings, blood clots, and fertility myths. These concerns lead to reluctance in adoption, discontinuation of use, and hesitancy to try new methods, particularly among first-time users.

Market Trends

• Surge in Demand for Long-Acting Reversible Contraceptives (LARCs) : IUDs and implants are gaining popularity globally due to their high efficacy, low maintenance, and long-term protection. LARCs are increasingly preferred by women looking for convenient and cost-effective solutions that do not require daily attention, and they are being actively promoted in family planning programs.
• Growth of Digital Health and Telecontraception Platforms: Digital health startups are disrupting the industry with online consultations, home-delivery of contraceptives, fertility tracking apps, and virtual birth control prescriptions. These platforms offer privacy, accessibility, and education—especially appealing to tech-savvy, younger populations seeking discreet reproductive healthcare.

Contraceptive drugs are leading the contraceptive market due to their high efficacy, ease of use, and widespread availability through both prescriptions and over-the-counter channels.

Contraceptive drugs, particularly oral contraceptive pills, dominate the global contraceptive market because they offer a highly effective, convenient, and non-invasive method of preventing pregnancy that aligns well with the lifestyles of millions of women worldwide. These drugs are widely trusted due to their long history of clinical use, with many formulations now offering additional health benefits such as regulation of menstrual cycles, reduction in acne, and management of hormonal disorders like PCOS (polycystic ovary syndrome). Their popularity is also bolstered by the fact that they do not require clinical procedures or devices, making them more accessible to women in both developed and developing countries. Additionally, contraceptive pills come in a range of hormone compositions, allowing healthcare providers to tailor recommendations based on individual health profiles. The availability of emergency contraceptive pills and the increasing use of digital health platforms for online consultations and doorstep delivery have further contributed to their dominance.

The 15–44 years age group is leading in the contraceptive market because it represents the primary reproductive age range with the highest demand for family planning and fertility control.

The 15–44 years age group dominates the contraceptive market because it encompasses the most biologically fertile and socially active segment of the population, where the need for pregnancy prevention is most prevalent. Individuals within this age bracket are typically at the center of their reproductive years—planning families, managing spacing between children, or choosing to delay parenthood for personal, educational, or career-related reasons. This group is also the most targeted by sexual and reproductive health programs, awareness campaigns, and educational initiatives that emphasize the importance of safe sex and family planning. Women in this age group are more likely to seek healthcare guidance, participate in modern contraceptive methods, and have greater exposure to product choices including pills, condoms, IUDs, implants, and emergency contraception. Furthermore, as societal norms shift and more people pursue higher education and career development, there’s a growing trend toward delaying childbirth, which directly fuels the demand for reliable contraceptive options among this demographic. Healthcare systems, governments, and private companies often focus their contraceptive marketing, subsidies, and innovation efforts on this age group due to its high reproductive activity, making it the leading contributor to contraceptive usage and market growth globally.

Females lead the contraceptive market because the majority of available contraceptive methods are designed for and predominantly used by women, offering them greater control over reproductive health decisions.

The contraceptive market is largely driven by female users because most existing and widely adopted contraceptive methods—such as oral pills, intrauterine devices (IUDs), implants, injectables, vaginal rings, and female sterilization—are specifically designed for women. Historically, family planning and reproductive health programs have focused on empowering women with options to control fertility and prevent unintended pregnancies, which has resulted in a broader range of products, clinical support, and educational resources directed toward female contraceptive use. Women are also more likely than men to seek routine healthcare services, making them more engaged in discussions around contraception with healthcare providers. Additionally, societal expectations and cultural norms often place the responsibility of family planning on women, reinforcing their active participation in choosing and using contraceptive methods. While male methods like condoms and vasectomy exist, their usage rates are comparatively lower, and innovation in male contraceptives is still in early stages.

Retail pharmacies lead the contraceptive market because they offer convenient, accessible, and discreet access to a wide range of contraceptive products without the need for extensive medical consultation.

Retail pharmacies play a dominant role in the contraceptive market primarily because they serve as easily accessible points of purchase for a variety of contraceptive products such as oral pills, condoms, emergency contraception, and even some over-the-counter hormonal options. In both urban and rural areas, pharmacies are often the first line of contact for individuals seeking contraceptive solutions due to their widespread presence, extended operating hours, and the ability to offer a degree of privacy compared to clinics or hospitals. Many users, especially young adults and those concerned about social stigma, prefer pharmacies for their discreet purchasing experience. Additionally, the expansion of pharmacy chains and the integration of digital platforms that allow for online ordering and home delivery have significantly enhanced the reach and ease of obtaining contraceptives. Pharmacists in many countries are also increasingly authorized to offer guidance on contraceptive use, which further boosts consumer confidence.

Asia-Pacific is leading in the contraceptive market due to its large reproductive-age population, increasing government initiatives for family planning, and growing awareness about reproductive health.

The Asia-Pacific region dominates the global contraceptive market primarily because of its immense population base, particularly within the reproductive age group of 15–44 years, which naturally drives high demand for contraceptive products and services. Countries like China, India, Indonesia, and Bangladesh have long recognized the importance of population control and reproductive health, leading to the implementation of large-scale government-supported family planning programs. These initiatives have not only increased access to contraceptives through public healthcare systems and outreach efforts but also raised awareness about the importance of spacing and planning pregnancies. Additionally, rising education levels, urbanization, and greater participation of women in the workforce have created a cultural shift toward smaller, planned families. The availability of low-cost contraceptives, growing investments by both public and private players, and increasing distribution through retail pharmacies and online platforms further support market growth.

• In March 2024, Perrigo Company plc announced the availability of its oral contraceptive pill, Opill, without a prescription in the U.S. It is also available for sale online on the company's website.
• In October 2023, Xiromed launched a generic version of Nuvaring, a vaginal ring, EnilloRing. The launch of this product offers an additional contraceptive option to patients in the U.S.
• In April 2023, Veru Inc. entered into an agreement with Afaxys Group Services, LLC (AGS) to distribute FC2 Female Condom of Veru with the support of AGS's Group Purchasing Organization (GPO). This partnership aims to support over 31 million individuals who depend on public health and community centers for essential healthcare services, benefiting both men and women.
• In March 2023, NEXT Life Sciences, Inc., a medical device company, launched a new contraceptive product for men to market, Plan A. The development of this product is to offer fully reversible birth control, safe and effective for men.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Contraceptive Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Contraceptive Drugs
• Contraceptive Devices

By Age Group
• 15 - 44 years
• Above 44 years

By Gender
• Female
• Male

By Distribution Channels
• Retail pharmacies
• Hospital pharmacies
• Online channels
• Other distribution channels

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents

Table of Content

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.3.1. XXXX
2.3.2. XXXX
2.3.3. XXXX
2.3.4. XXXX
2.3.5. XXXX
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Contraceptive Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Product
6.4.1. Market Size and Forecast, By Contraceptive Drugs
6.4.2. Market Size and Forecast, By Contraceptive Devices
6.5. Market Size and Forecast, By Age Group
6.6. Market Size and Forecast, By Gender
6.7. Market Size and Forecast, By End-User
6.8. Market Size and Forecast, By Distribution Channels
7. North America Contraceptive Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Product
7.4. Market Size and Forecast, By Age Group
7.5. Market Size and Forecast, By Gender
7.6. Market Size and Forecast, By End-User
7.7. Market Size and Forecast, By Distribution Channels
7.8. United States Contraceptive Market Outlook
7.8.1. Market Size by Value
7.8.2. Market Size and Forecast By Product
7.8.3. Market Size and Forecast By Age Group
7.8.4. Market Size and Forecast By Gender
7.8.5. Market Size and Forecast, By Distribution Channels
7.9. Canada Contraceptive Market Outlook
7.9.1. Market Size by Value
7.9.2. Market Size and Forecast By Product
7.9.3. Market Size and Forecast By Age Group
7.9.4. Market Size and Forecast By Gender
7.9.5. Market Size and Forecast, By Distribution Channels
7.10. Mexico Contraceptive Market Outlook
7.10.1. Market Size by Value
7.10.2. Market Size and Forecast By Product
7.10.3. Market Size and Forecast By Age Group
7.10.4. Market Size and Forecast By Gender
7.10.5. Market Size and Forecast, By Distribution Channels
8. Europe Contraceptive Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Product
8.4. Market Size and Forecast, By Age Group
8.5. Market Size and Forecast, By Gender
8.6. Market Size and Forecast, By End-User
8.7. Market Size and Forecast, By Distribution Channels
8.8. Germany Contraceptive Market Outlook
8.8.1. Market Size by Value
8.8.2. Market Size and Forecast By Product
8.8.3. Market Size and Forecast By Age Group
8.8.4. Market Size and Forecast By Gender
8.8.5. Market Size and Forecast, By Distribution Channels
8.9. United Kingdom (UK) Contraceptive Market Outlook
8.9.1. Market Size by Value
8.9.2. Market Size and Forecast By Product
8.9.3. Market Size and Forecast By Age Group
8.9.4. Market Size and Forecast By Gender
8.9.5. Market Size and Forecast, By Distribution Channels
8.10. France Contraceptive Market Outlook
8.10.1. Market Size by Value
8.10.2. Market Size and Forecast By Product
8.10.3. Market Size and Forecast By Age Group
8.10.4. Market Size and Forecast By Gender
8.10.5. Market Size and Forecast, By Distribution Channels
8.11. Italy Contraceptive Market Outlook
8.11.1. Market Size by Value
8.11.2. Market Size and Forecast By Product
8.11.3. Market Size and Forecast By Age Group
8.11.4. Market Size and Forecast By Gender
8.11.5. Market Size and Forecast, By Distribution Channels
8.12. Spain Contraceptive Market Outlook
8.12.1. Market Size by Value
8.12.2. Market Size and Forecast By Product
8.12.3. Market Size and Forecast By Age Group
8.12.4. Market Size and Forecast By Gender
8.12.5. Market Size and Forecast, By Distribution Channels
8.13. Russia Contraceptive Market Outlook
8.13.1. Market Size by Value
8.13.2. Market Size and Forecast By Product
8.13.3. Market Size and Forecast By Age Group
8.13.4. Market Size and Forecast By Gender
8.13.5. Market Size and Forecast, By Distribution Channels
9. Asia-Pacific Contraceptive Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Product
9.4. Market Size and Forecast, By Age Group
9.5. Market Size and Forecast, By Gender
9.6. Market Size and Forecast, By End-User
9.7. Market Size and Forecast, By Distribution Channels
9.8. China Contraceptive Market Outlook
9.8.1. Market Size by Value
9.8.2. Market Size and Forecast By Product
9.8.3. Market Size and Forecast By Age Group
9.8.4. Market Size and Forecast By Gender
9.8.5. Market Size and Forecast, By Distribution Channels
9.9. Japan Contraceptive Market Outlook
9.9.1. Market Size by Value
9.9.2. Market Size and Forecast By Product
9.9.3. Market Size and Forecast By Age Group
9.9.4. Market Size and Forecast By Gender
9.9.5. Market Size and Forecast, By Distribution Channels
9.10. India Contraceptive Market Outlook
9.10.1. Market Size by Value
9.10.2. Market Size and Forecast By Product
9.10.3. Market Size and Forecast By Age Group
9.10.4. Market Size and Forecast By Gender
9.10.5. Market Size and Forecast, By Distribution Channels
9.11. Australia Contraceptive Market Outlook
9.11.1. Market Size by Value
9.11.2. Market Size and Forecast By Product
9.11.3. Market Size and Forecast By Age Group
9.11.4. Market Size and Forecast By Gender
9.11.5. Market Size and Forecast, By Distribution Channels
9.12. South Korea Contraceptive Market Outlook
9.12.1. Market Size by Value
9.12.2. Market Size and Forecast By Product
9.12.3. Market Size and Forecast By Age Group
9.12.4. Market Size and Forecast By Gender
9.12.5. Market Size and Forecast, By Distribution Channels
10. South America Contraceptive Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Product
10.4. Market Size and Forecast, By Age Group
10.5. Market Size and Forecast, By Gender
10.6. Market Size and Forecast, By End-User
10.7. Market Size and Forecast, By Distribution Channels
10.8. Brazil Contraceptive Market Outlook
10.8.1. Market Size by Value
10.8.2. Market Size and Forecast By Product
10.8.3. Market Size and Forecast By Age Group
10.8.4. Market Size and Forecast By Gender
10.8.5. Market Size and Forecast, By Distribution Channels
10.9. Argentina Contraceptive Market Outlook
10.9.1. Market Size by Value
10.9.2. Market Size and Forecast By Product
10.9.3. Market Size and Forecast By Age Group
10.9.4. Market Size and Forecast By Gender
10.9.5. Market Size and Forecast, By Distribution Channels
10.10. Colombia Contraceptive Market Outlook
10.10.1. Market Size by Value
10.10.2. Market Size and Forecast By Product
10.10.3. Market Size and Forecast By Age Group
10.10.4. Market Size and Forecast By Gender
10.10.5. Market Size and Forecast, By Distribution Channels
11. Middle East & Africa Contraceptive Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Product
11.4. Market Size and Forecast, By Age Group
11.5. Market Size and Forecast, By Gender
11.6. Market Size and Forecast, By End-User
11.7. Market Size and Forecast, By Distribution Channels
11.8. United Arab Emirates (UAE) Contraceptive Market Outlook
11.8.1. Market Size by Value
11.8.2. Market Size and Forecast By Product
11.8.3. Market Size and Forecast By Age Group
11.8.4. Market Size and Forecast By Gender
11.8.5. Market Size and Forecast, By Distribution Channels
11.9. Saudi Arabia Contraceptive Market Outlook
11.9.1. Market Size by Value
11.9.2. Market Size and Forecast By Product
11.9.3. Market Size and Forecast By Age Group
11.9.4. Market Size and Forecast By Gender
11.9.5. Market Size and Forecast, By Distribution Channels
11.10. South Africa Contraceptive Market Outlook
11.10.1. Market Size by Value
11.10.2. Market Size and Forecast By Product
11.10.3. Market Size and Forecast By Age Group
11.10.4. Market Size and Forecast By Gender
11.10.5. Market Size and Forecast, By Distribution Channels
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Key Players Market Share Insights and Analysis, 2024
12.4. Key Players Market Positioning Matrix
12.5. Porter's Five Forces
12.6. Company Profile
12.6.1. AbbVie, Inc.
12.6.1.1. Company Snapshot
12.6.1.2. Company Overview
12.6.1.3. Financial Highlights
12.6.1.4. Geographic Insights
12.6.1.5. Business Segment & Performance
12.6.1.6. Product Portfolio
12.6.1.7. Key Executives
12.6.1.8. Strategic Moves & Developments
12.6.2. Bayer AG
12.6.3. Reckitt Benckiser Group plc
12.6.4. Mankind Pharma Limited
12.6.5. Exeltis
12.6.6. Pfizer, Inc.
12.6.7. The Cooper Companies, Inc.
12.6.8. Glenmark Pharmaceuticals Limited
12.6.9. Johnson & Johnson
12.6.10. Merck & Co., Inc.
12.6.11. Lupin Limited
12.6.12. Afaxys, Inc.
12.6.13. Femasys Inc.
12.6.14. Church & Dwight Co., Inc.
12.6.15. Teva Pharmaceutical Industries Ltd.
12.6.16. Aurobindo Pharma Limited
12.6.17. Okamoto Industries, Inc.
12.6.18. Cipla Limited
12.6.19. HLL Lifecare Limited
12.6.20. Pregna International Ltd.
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
14.3. Related Reports
15. Disclaimer

 

ページTOPに戻る

List of Tables/Graphs

List of Figures

Figure 1: Global Contraceptive Market Size (USD Billion) By Region, 2024 & 2030
Figure 2: Market attractiveness Index, By Region 2030
Figure 3: Market attractiveness Index, By Segment 2030
Figure 4: Global Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 5: Global Contraceptive Market Share By Region (2024)
Figure 6: North America Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 7: North America Contraceptive Market Share By Country (2024)
Figure 8: US Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 9: Canada Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 10: Mexico Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 11: Europe Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 12: Europe Contraceptive Market Share By Country (2024)
Figure 13: Germany Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 14: United Kingdom (UK) Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 15: France Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 16: Italy Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 17: Spain Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 18: Russia Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 19: Asia-Pacific Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 20: Asia-Pacific Contraceptive Market Share By Country (2024)
Figure 21: China Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 22: Japan Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 23: India Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 24: Australia Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 25: South Korea Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 26: South America Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 27: South America Contraceptive Market Share By Country (2024)
Figure 28: Brazil Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 29: Argentina Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 30: Colombia Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 31: Middle East & Africa Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 32: Middle East & Africa Contraceptive Market Share By Country (2024)
Figure 33: United Arab Emirates (UAE) Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 34: Saudi Arabia Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 35: South Africa Contraceptive Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 36: Porter's Five Forces of Global Contraceptive Market
 

List of Tables

Table 1: Global Contraceptive Market Snapshot, By Segmentation (2024 & 2030) (in USD Billion)
Table 2: Influencing Factors for Contraceptive Market, 2024
Table 3: Top 10 Counties Economic Snapshot 2022
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Contraceptive Market Size and Forecast, By Geography (2019 to 2030F) (In USD Million)
Table 7: Global Contraceptive Market Size and Forecast, By Product (2019 to 2030F) (In USD Million)
Table 8: Global Contraceptive Market Size and Forecast, By Contraceptive Drugs (2019 to 2030F) (In USD Million)
Table 9: Global Contraceptive Market Size and Forecast, By Contraceptive Devices (2019 to 2030F) (In USD Million)
Table 10: Global Contraceptive Market Size and Forecast, By Age Group (2019 to 2030F) (In USD Million)
Table 11: Global Contraceptive Market Size and Forecast, By Gender (2019 to 2030F) (In USD Million)
Table 12: Global Contraceptive Market Size and Forecast, By End-User (2019 to 2030F) (In USD Million)
Table 13: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 14: North America Contraceptive Market Size and Forecast, By Product (2019 to 2030F) (In USD Million)
Table 15: North America Contraceptive Market Size and Forecast, By Age Group (2019 to 2030F) (In USD Million)
Table 16: North America Contraceptive Market Size and Forecast, By Gender (2019 to 2030F) (In USD Million)
Table 17: Global Contraceptive Market Size and Forecast, By End-User (2019 to 2030F) (In USD Million)
Table 18: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 19: United States Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 20: United States Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 21: United States Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 22: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 23: Canada Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 24: Canada Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 25: Canada Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 26: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 27: Mexico Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 28: Mexico Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 29: Mexico Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 30: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 31: Europe Contraceptive Market Size and Forecast, By Product (2019 to 2030F) (In USD Million)
Table 32: Europe Contraceptive Market Size and Forecast, By Age Group (2019 to 2030F) (In USD Million)
Table 33: Europe Contraceptive Market Size and Forecast, By Gender (2019 to 2030F) (In USD Million)
Table 34: Global Contraceptive Market Size and Forecast, By End-User (2019 to 2030F) (In USD Million)
Table 35: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 36: Germany Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 37: Germany Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 38: Germany Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 39: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 40: United Kingdom (UK) Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 41: United Kingdom (UK) Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 42: United Kingdom (UK) Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 43: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 44: France Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 45: France Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 46: France Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 47: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 48: Italy Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 49: Italy Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 50: Italy Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 51: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 52: Spain Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 53: Spain Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 54: Spain Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 55: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 56: Russia Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 57: Russia Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 58: Russia Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 59: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 60: Asia-Pacific Contraceptive Market Size and Forecast, By Product (2019 to 2030F) (In USD Million)
Table 61: Asia-Pacific Contraceptive Market Size and Forecast, By Age Group (2019 to 2030F) (In USD Million)
Table 62: Asia-Pacific Contraceptive Market Size and Forecast, By Gender (2019 to 2030F) (In USD Million)
Table 63: Global Contraceptive Market Size and Forecast, By End-User (2019 to 2030F) (In USD Million)
Table 64: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 65: China Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 66: China Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 67: China Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 68: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 69: Japan Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 70: Japan Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 71: Japan Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 72: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 73: India Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 74: India Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 75: India Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 76: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 77: Australia Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 78: Australia Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 79: Australia Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 80: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 81: South Korea Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 82: South Korea Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 83: South Korea Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 84: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 85: South America Contraceptive Market Size and Forecast, By Product (2019 to 2030F) (In USD Million)
Table 86: South America Contraceptive Market Size and Forecast, By Age Group (2019 to 2030F) (In USD Million)
Table 87: South America Contraceptive Market Size and Forecast, By Gender (2019 to 2030F) (In USD Million)
Table 88: Global Contraceptive Market Size and Forecast, By End-User (2019 to 2030F) (In USD Million)
Table 89: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 90: Brazil Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 91: Brazil Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 92: Brazil Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 93: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 94: Argentina Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 95: Argentina Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 96: Argentina Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 97: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 98: Colombia Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 99: Colombia Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 100: Colombia Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 101: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 102: Middle East & Africa Contraceptive Market Size and Forecast, By Product (2019 to 2030F) (In USD Million)
Table 103: Middle East & Africa Contraceptive Market Size and Forecast, By Age Group (2019 to 2030F) (In USD Million)
Table 104: Middle East & Africa Contraceptive Market Size and Forecast, By Gender (2019 to 2030F) (In USD Million)
Table 105: Global Contraceptive Market Size and Forecast, By End-User (2019 to 2030F) (In USD Million)
Table 106: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 107: United Arab Emirates (UAE) Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 108: United Arab Emirates (UAE) Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 109: United Arab Emirates (UAE) Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 110: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 111: Saudi Arabia Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 112: Saudi Arabia Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 113: Saudi Arabia Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 114: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 115: South Africa Contraceptive Market Size and Forecast By Product (2019 to 2030F) (In USD Million)
Table 116: South Africa Contraceptive Market Size and Forecast By Age Group (2019 to 2030F) (In USD Million)
Table 117: South Africa Contraceptive Market Size and Forecast By Gender (2019 to 2030F) (In USD Million)
Table 118: Global Contraceptive Market Size and Forecast, By Distribution Channels (2019 to 2030F) (In USD Million)
Table 119: Competitive Dashboard of top 5 players, 2024
Table 120: Key Players Market Share Insights and Anaylysis for Contraceptive Market 2024